Simcere Pharmaceutical Group Limited (HKG:2096)

HKG:2096 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	30,488	17,653	17,611	30,914	23,628	23,347
Market Cap Growth	0.24%	0.24%	-43.03%	30.83%	1.20%	-
Enterprise Value	29,707	15,639	16,205	29,371	23,209	26,834
Last Close Price	12.32	6.98	6.42	10.84	8.23	8.09
PE Ratio	39.92	22.63	22.37	29.38	12.77	29.36
Forward PE	24.51	14.35	12.11	29.04	26.63	18.00
PS Ratio	4.32	2.50	2.42	4.32	3.85	4.36
PB Ratio	4.05	2.35	2.21	3.83	2.98	3.68
P/TBV Ratio	4.86	2.81	2.51	4.16	3.10	3.89
P/FCF Ratio	27.70	16.04	-	27.04	-	-
P/OCF Ratio	20.59	11.93	105.83	20.19	-	203.24
PEG Ratio	-	1.12	1.12	1.12	1.12	-
EV/Sales Ratio	4.21	2.22	2.23	4.11	3.78	5.01
EV/EBITDA Ratio	19.44	10.83	15.90	31.86	44.76	29.79
EV/EBIT Ratio	24.59	12.97	20.69	42.85	81.03	37.66
EV/FCF Ratio	26.99	14.21	-	25.69	-	-
Debt / Equity Ratio	0.17	0.17	0.20	0.21	0.25	0.62
Debt / EBITDA Ratio	0.84	0.84	1.43	1.72	3.50	4.10
Debt / FCF Ratio	1.17	1.17	-	1.49	-	-
Asset Turnover	0.59	0.59	0.61	0.60	0.47	0.51
Inventory Turnover	1.80	1.80	2.84	4.01	3.59	2.94
Quick Ratio	1.73	1.73	1.76	1.69	1.51	1.48
Current Ratio	2.00	2.00	2.10	1.84	1.63	1.85
Return on Equity (ROE)	10.26%	10.26%	9.94%	13.62%	25.41%	19.49%
Return on Assets (ROA)	6.33%	6.33%	4.11%	3.62%	1.38%	4.23%
Return on Capital (ROIC)	8.37%	8.37%	5.13%	4.52%	1.74%	5.74%
Return on Capital Employed (ROCE)	12.90%	12.90%	8.70%	7.80%	3.30%	8.10%
Earnings Yield	2.56%	4.42%	4.47%	3.40%	7.83%	3.41%
FCF Yield	3.61%	6.23%	-2.08%	3.70%	-2.14%	-1.30%
Dividend Yield	1.41%	2.44%	2.74%	1.67%	2.24%	2.20%
Payout Ratio	54.76%	54.76%	58.65%	42.04%	25.96%	-
Buyback Yield / Dilution	3.40%	3.40%	0.45%	-0.34%	-9.14%	-2.03%
Total Shareholder Return	4.80%	5.83%	3.19%	1.32%	-6.91%	0.18%

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.